Approval · Notice of Compliance 672 · 2002
PROVOCHOLINE: Notice of Compliance 672
Issued September 26, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 672
- Date
- September 26, 2002
- Company
- Methapharm Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strengths
- Therapeutic class
- Cholinergic/diagnostic aid (bronchial asthma)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROVOCHOLINE | 02246492 | Dormant |
| PROVOCHOLINE | 02246493 | Dormant |
Medicinal ingredients
- METHACHOLINE CHLORIDE 160 MG per VIAL
- METHACHOLINE CHLORIDE 320 MG per VIAL